Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Understanding climate change in America: Skepticism, dogmatism and personal experience18.12.2025 - 2American tourists left stranded in the Caribbean following flight cancellations after airspace closed for Maduro operation05.01.2026
- 3The 10 Most Persuasive Forerunners in Innovation06.07.2023
- 4EU Council president: Ukraine should receive binding guarantees06.01.2026
- 5Figuring out Significant Regulations and Guidelines for Organizations30.06.2023
- Shas threatens to oppose 2026 state budget over haredi food-voucher exclusion
- Virtual reality opens doors for older people to build closer connections in real life
- Shipping: The Corridors of Trade and the Coming of Another Period
- Brexit's Effect on New York's Ascent as a Main Monetary Center
- Working out at the airport? Some fliers can already smell the sweat.
- The Way to Monetary Health: Individual budget Change
- A new mom skipped a routine appointment. An infected cut led to a devastating diagnosis
- NASA, in a rare move, cuts space station mission short after an astronaut's medical issue
- The Best Portable Applications for Emotional wellness and Prosperity
